Table 4. Vκ and Vλ gene sequences of CD20+CD27+ EBV-infected B cells.
Cell | Vκ/λ gene* | Jκ/λ gene† | No. of mutations (%) | % of mutations, VH gene‡ |
---|---|---|---|---|
IM2-1 | Vλ2-14 | Jλ1 | 10 (3.5) | 7.1 |
IM2-3 | Vλ3-21 | Jλ3 | 9 (3.2) | 5.4 |
IM2-4 | Vλ3-10 | Jλ3 | 30 (10.2) | 10.5 |
IM2-5 | Vλ3-9 | Jλ3 | 8 (2.7) | 3.0 |
IM2-6 | Vκ3-15 | NA | 13 (4.6) | - |
IM2-7 | Vκ1-5 | NA | 6 (2.2) | - |
IM2-8 | Vκ2D40 | Jκ5 | 3 (1.0) | - |
IM2-9 | Vκ3-20 | Jκ1 | 11 (3.8) | - |
IM3-6 | Vκ1D-39 | Jκ3 | 7 (2.5) | - |
IM4-1 | Vλ1-47 | Jλ3 | 0 (0) | 3.1 |
IM4-2 | Vλ2-11 | Jλ3 | 23 (7.8) | 8.1 |
IM4-7 | Vλ1-40 | Jλ1 | 18 (6.3) | - |
IM4-8 | Vκ3-20 | Jκ1 | 14 (5.0) | - |
IM4-9 | Vκ1-27 | NA | 2 (0.7) | - |
IM4-10 | Vκ3-11 | Jκ1 | 7 (2.5) | - |
IM5-6 | Vκ3-20 | Jκ3 | 6 (2.1) | - |
IM5-7 | Vκ1D-39 | Jκ1 | 9 (3.2) | - |
Means (n = 17) | 10.4 (3.6) | 6.2 |